Project Management

Project Management and Oversight (WP1)

Coordinator

Wan-Fai Ng
University of Newcastle upon Tyne

Co-Coordinator

Walter Maetzler
Universitätsklinikum Schleswig-Holstein

Project Lead

Nikolay Manyakov
Janssen Pharmaceutica NV

Project Co-Lead

Geert Van Gassen

Takeda Pharmaceuticals International AG

Project Manager

David Wenn
iXscient Ltd

Project Manager

Mike Jackson
iXscient Ltd

Industry Project Manager

Dario Masullo
Janssen Pharmaceutica NV

Clinical Knowledge and Insight (WP2)

Academic Lead

Walter Maetzler
Universitätsklinikum Schleswig-Holstein

Industry Lead

Armella Escher
Takeda Development Centre Europe Ltd

Digital Device and Technology (WP3)

Academic Lead

Christopher Bull
University of Newcastle upon Tyne

Industry Lead

Kenneth Mosca
Janssen Pharmaceutica NV

Device-specific Data Analytics and Performance Assessment (WP4)

Academic Lead

Teemu Ahmaniemi
Teknologian tutkimuskeskus VTT Oy

Industry Lead

Meenakshi Chatterjee
Janssen Pharmaceutica NV

Data Management (WP5)

Academic Lead

Yi-Ke Guo
Imperial College of Science Technology and Medicine

Academic Co-Lead

Kai Sun
Imperial College of Science Technology and Medicine

Industry Lead

Ioannis Pandis
Janssen Pharmaceutica NV

Clinical Study Organisation & Management (WP6)

Academic Lead

Wan-Fai Ng
University of Newcastle upon Tyne

Industry Co-Lead

Nadir Ammour
Sanofi Aventis Recherche et Développement

Study Sponsor

Walter Maetzler
Universitätsklinikum Schleswig-Holstein

Statistical Inference Design and Learning (WP7)

Academic Lead

Jérôme Kalifa
Let it Care SAS

Industry Lead

Stefan Avey
Janssen Pharmaceutica NV

Data Protection, Ethics and Legal Challenges (WP8)

Academic Lead

Evert-Ben van Veen
Stichting MLC Foundation

Industry Lead

Geert Van Gassen
Takeda Pharmaceuticals International AG

Dissemination, Exploitation & Sustainability (WP9)

Academic Lead

Veli Stroetmann
empirica Gesellschaft für Kommunikations und Technologieforschung Mbh

Industry Lead

David Nobbs
F. Hoffmann-La Roche AG

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.

Copyright 2022 IDEA-FAST